Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margarita E Neganova

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Seminars in Cancer Biology|August 20, 2020
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progressMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Current Medicinal Chemistry|December 21, 2020
The Hydroxamic Acids as Potential Anticancer and Neuroprotective AgentsMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Seminars in Cancer Biology|July 2, 2022
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disordersMargarita E Neganova, Yulia R Aleksandrova, Olga A Sukocheva, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2022
Synthesis and biological testing of 3,5-bis(arylidene)-4-piperidone conjugates with 2,5-dihydro-5H-1,2-oxaphospholenesMargarita E Neganova, Yulia R Aleksandrova, Natalia S Nikolaeva, et al.
Seminars in Cancer Biology|August 26, 2019
Implications of nanotechnology for the treatment of cancer: Recent advancesSergey G Klochkov, Margarita E Neganova, Vladimir N Nikolenko, et al.
Frontiers in Cell and Developmental Biology|October 18, 2023
Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancersDeyao Zhao, Yingyi Mo, Margarita E Neganova, et al.
Current Medicinal Chemistry|March 19, 2025
Analysis of the Main Directions in the Development of Mono and Combination Pharmacotherapy Acting on Hormonal Signaling Pathways of Breast Cancer According to the FDA Databases and Clinicaltrials.govSabina Abdullaeva, Polina Abdullaeva, Renata Gabdrahimova, et al.
Molecular Neurobiology|July 16, 2018
Pharmacological Sequestration of Mitochondrial Calcium Uptake Protects Neurons Against Glutamate ExcitotoxicityPlamena R Angelova, Darya Vinogradova, Margarita E Neganova, et al.
Cell Communication and Signaling : CCS|May 2, 2024
Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapyOlga A Sukocheva, Margarita E Neganova, Yulia Aleksandrova, et al.
CNS & Neurological Disorders Drug Targets|April 26, 2017
Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer's DiseaseElena F Shevtsova, Daria V Vinogradova, Margarita E Neganova, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Seminars in Cancer Biology|August 20, 2020
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progressMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Current Medicinal Chemistry|December 21, 2020
The Hydroxamic Acids as Potential Anticancer and Neuroprotective AgentsMargarita E Neganova, Sergey G Klochkov, Yulia R Aleksandrova, et al.
Seminars in Cancer Biology|July 2, 2022
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disordersMargarita E Neganova, Yulia R Aleksandrova, Olga A Sukocheva, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2022
Synthesis and biological testing of 3,5-bis(arylidene)-4-piperidone conjugates with 2,5-dihydro-5H-1,2-oxaphospholenesMargarita E Neganova, Yulia R Aleksandrova, Natalia S Nikolaeva, et al.
Seminars in Cancer Biology|August 26, 2019
Implications of nanotechnology for the treatment of cancer: Recent advancesSergey G Klochkov, Margarita E Neganova, Vladimir N Nikolenko, et al.
Frontiers in Cell and Developmental Biology|October 18, 2023
Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancersDeyao Zhao, Yingyi Mo, Margarita E Neganova, et al.
Current Medicinal Chemistry|March 19, 2025
Analysis of the Main Directions in the Development of Mono and Combination Pharmacotherapy Acting on Hormonal Signaling Pathways of Breast Cancer According to the FDA Databases and Clinicaltrials.govSabina Abdullaeva, Polina Abdullaeva, Renata Gabdrahimova, et al.
Molecular Neurobiology|July 16, 2018
Pharmacological Sequestration of Mitochondrial Calcium Uptake Protects Neurons Against Glutamate ExcitotoxicityPlamena R Angelova, Darya Vinogradova, Margarita E Neganova, et al.
Cell Communication and Signaling : CCS|May 2, 2024
Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapyOlga A Sukocheva, Margarita E Neganova, Yulia Aleksandrova, et al.
CNS & Neurological Disorders Drug Targets|April 26, 2017
Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer's DiseaseElena F Shevtsova, Daria V Vinogradova, Margarita E Neganova, et al.
Pageof 4